iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.85M
Expense Ratio	0.47%
PE Ratio	n/a
Shares Out	150,000
Dividend (ttm)	$0.01
Dividend Yield	0.05%
Ex-Dividend Date	Dec 20, 2023
Payout Ratio	n/a
1-Year Return	+24.71%

Volume	1,194
Open	25.97
Previous Close	25.77
Day's Range	25.91 - 25.97
52-Week Low	20.94
52-Week High	28.74
Beta	0.69
Holdings	66
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

40.20% of assets

Name	Symbol	Weight
PTC Therapeutics, Inc.	PTCT	4.63%
Biohaven Ltd.	BHVN	4.48%
Intra-Cellular Therapies, Inc.	ITCI	4.22%
Alkermes plc	ALKS	3.90%
ACADIA Pharmaceuticals Inc.	ACAD	3.88%
argenx SE	ARGX	3.87%
Catalyst Pharmaceuticals, Inc.	CPRX	3.87%
Xenon Pharmaceuticals Inc.	XENE	3.85%
Axonics, Inc.	AXNX	3.84%
Longboard Pharmaceuticals, Inc.	LBPH	3.66%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2023	$0.006	Dec 27, 2023
Jun 7, 2023	$0.008	Jun 13, 2023